Literature DB >> 2344622

Identification of a potent new pathogenic site in human retinal S-antigen which induces experimental autoimmune uveoretinitis in LEW rats.

D S Gregerson1, C F Merryman, W F Obritsch, L A Donoso.   

Abstract

Experimental autoimmune uveoretinitis (EAU) is a T cell-mediated autoimmune disease of the eye which can be induced in LEW rats by immunization with either human or bovine S-antigen (S-Ag). In previous reports, two nonimmunodominant pathogenic sites were found using synthetic peptides corresponding to conserved sequences at amino acid residues 303-314 and 286-297 of the bovine sequence. In this report, a 20-residue synthetic peptide encompassing amino acids 343-362 located near the C-terminus was found to be highly immunopathogenic in LEW rats. The onset of EAU was observed at as early as 8 days when high doses of a peptide-encompassing residues 343-362 were used. EAU was elicited with as little as 0.5 microgram of peptide per animal. Smaller peptides from this region were also tested for uveitogenicity, further refining the site to 13 amino acids. Uveitogenic T cell lines were made to this site in two ways; first, by the in vitro selection of a bulk T cell line raised to human S-Ag with peptide 343-362. Second, by the in vitro selection of a peptide-specific line from an animal immunized with peptide 352-364, which corresponds to the minimal uveitogenic site. Both of these lines adoptively transferred EAU to LEW rats, further establishing the pathogenicity of this site. A proliferative site distinct from, but overlapping, the uveitogenic site was also found. The potent uveitopathogenicity of peptides from this region indicates that it is a major pathogenic site responsible for EAU induced in LEW rats by immunization with human S-Ag.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2344622     DOI: 10.1016/0008-8749(90)90019-n

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  10 in total

1.  Definition of the HLA-A29 peptide ligand motif allows prediction of potential T-cell epitopes from the retinal soluble antigen, a candidate autoantigen in birdshot retinopathy.

Authors:  F Boisgerault; I Khalil; V Tieng; F Connan; T Tabary; J H Cohen; J Choppin; D Charron; A Toubert
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

2.  Rodent models of experimental autoimmune uveitis.

Authors:  Rajeev K Agarwal; Phyllis B Silver; Rachel R Caspi
Journal:  Methods Mol Biol       Date:  2012

Review 3.  Cytokines in posterior uveitis: an update.

Authors:  V K Singh; G Rai
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

4.  Spontaneous retinopathy in HLA-A29 transgenic mice.

Authors:  Y Szpak; J C Vieville; T Tabary; M C Naud; M Chopin; C Edelson; J H Cohen; J Dausset; Y de Kozak; M Pla
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

Review 5.  Experimental autoimmune uveitis: molecular mimicry and oral tolerance.

Authors:  V K Singh; K Nagaraju
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

6.  Cellular immune responses of patients with juvenile chronic arthritis to retinal antigens and their synthetic peptides.

Authors:  D Gupta; V K Singh; J Rajasingh; T Shinohara; R Misra; S S Agarwal
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

7.  Cellular immune response of patients with uveitis to peptide M, a retinal S-antigen fragment.

Authors:  S Nityanand; V K Singh; T Shinohara; A K Paul; V Singh; P K Agarwal; S S Agarwal
Journal:  J Clin Immunol       Date:  1993-09       Impact factor: 8.317

8.  S-antigen specific T cell clones from a patient with Behçet's disease.

Authors:  J H Yamamoto; Y Fujino; C Lin; M Nieda; T Juji; K Masuda
Journal:  Br J Ophthalmol       Date:  1994-12       Impact factor: 4.638

9.  A pathogenic autoimmune process targeted at a surrogate epitope.

Authors:  A T Kozhich; Y Kawano; C E Egwuagu; R R Caspi; R K Maturi; J A Berzofsky; I Gery
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

Review 10.  The role of complement in ocular pathology.

Authors:  Nalini S Bora; Purushottam Jha; Puran S Bora
Journal:  Semin Immunopathol       Date:  2008-02-26       Impact factor: 9.623

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.